Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

2.0K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
2.0K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Autobiographical Memory in Alzheimer's Disease: Understanding to Better Support Patients].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2026
Same author

Effect of contextual and dispositional variables on protective behaviours in the face of imminent risk, as analysed using the virtual simulation of a tsunami.

Acta psychologica·2026
Same author

A memory lens on gender differences in romantic relationships.

The Behavioral and brain sciences·2026
Same author

Pupillometry as a Differential Indicator of Cognitive Processing in Alzheimer Disease and Behavioral Variant Frontotemporal Dementia.

Alzheimer disease and associated disorders·2026
Same author

Arabic Validation of the Noise-Induced Hearing Loss-Symptoms (NIHL-S) Scale Among Civilians Exposed to Loud Blasts During the 2024 Israeli Invasion of Lebanon.

Health science reports·2026
Same author

Disrupted emotion-memory interactions in behavioral variant frontotemporal dementia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Related Experiment Video

Updated: May 5, 2026

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

11.4K

Introducing ISPA-AD: Interactive social problem-solving assessment for Alzheimer's disease.

Claire Maussire1, Mohamad El Haj1, Etienne Emmelin2

  • 1Laboratory of Psychology of the Pays de la Loire, LPPL, UR 4638, Nantes University, University of Angers, Nantes, France.

Journal of Neuropsychology
|January 28, 2026
PubMed
Summary

Difficulties in social adaptation for individuals with Alzheimer's disease (AD) were explored using the new Interactive Social Problem-Solving Assessment for Alzheimer's Disease (ISPA-AD). The tool effectively identified social problem-solving deficits in AD patients.

Keywords:
Alzheimer's diseaseembodied cognitioninteractive assessmentsocial cognitionsocial problem‐solving

More Related Videos

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

3.1K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.5K

Related Experiment Videos

Last Updated: May 5, 2026

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

11.4K
Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

3.1K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.5K

Area of Science:

  • Neuroscience
  • Psychology
  • Gerontology

Background:

  • Social adaptation challenges in Alzheimer's disease (AD) are linked to impaired social cognition, such as theory of mind and emotion recognition.
  • Social problem-solving (SPS) is an understudied but critical factor in AD-related social deficits.

Purpose of the Study:

  • To develop and evaluate the Interactive Social Problem-Solving Assessment for Alzheimer's Disease (ISPA-AD), a novel tool for assessing SPS in AD.
  • To investigate the psychometric properties and discriminative ability of ISPA-AD.

Main Methods:

  • Development of ISPA-AD, featuring interactive scenarios to assess verbal and non-verbal SPS components.
  • Exploratory evaluation with 41 participants (19 AD patients, 22 healthy controls).
  • Psychometric analyses including internal consistency, construct validity, and discriminative ability.

Main Results:

  • ISPA-AD demonstrated good internal consistency (α = .811) and strong construct validity.
  • The tool showed excellent accuracy in differentiating AD patients from controls (AUC = .906).
  • AD patients performed significantly worse on SPS tasks, indicating specific deficit patterns.

Conclusions:

  • ISPA-AD offers a novel, ecologically relevant method for assessing SPS in Alzheimer's disease.
  • Preliminary findings support ISPA-AD's clinical utility for understanding social cognitive mechanisms in AD.
  • Further validation in larger, diverse samples and reliability studies are recommended.